Pancreatic Cancer: Current Progress and Future Challenges
Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, remains one of the highly lethal malignancies. The highly refractory nature of clinically advanced disease and lack of a reliable biomarker for early detection are major obstructions in improving patient outcome. The...
Main Author: | |
---|---|
Format: | Online |
Language: | English |
Published: |
Ivyspring International Publisher
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753155/ |